In some cases, GoodRx used the information to target people with health-related ads." The alert comes a month after the FTC announced a formal settlement with the digital health platform and ...
On February 1, 2023, the U.S. Federal Trade Commission (FTC) filed a proposed order implementing a permanent injunction and civil penalties against GoodRx in what the FTC called a “first-of-its-kind” ...
The Federal Trade Commission's recent actions against two companies in separate health data privacy cases are significant ...
The Federal Trade Commission (FTC) recently kicked off enforcement of its Health Breach Notification Rule (Breach Rule) by taking aim at GoodRx’s use of tracking technologies (e.g. pixels ...
Since 2020, the FTC has taken several actions to protect consumer health data collected online and in apps. In addition to GoodRx, the agency brought cases against period tracking app Flo Health ...
The complaint seeks to bring the full force of the FTC’s broad consumer protection powers to bear against what CAIDP portrayed as a Wild West of runaway experimentation in which consumers pay ...
The rule requires entities to report any breaches of consumer health information to the FTC. But until the GoodRx decision, the agency had yet to use its authority to penalize violations. To Gaurav ...
The complaint, made public by the nonprofit research group Center for AI and Digital Policy on Thursday, accuses OpenAI of violating Section 5 of the FTC Act, which prohibits unfair and deceptive ...
It seeks to hold OpenAI liable for violating Section 5 of the FTC Act, which prohibits unfair and deceptive trade practices. “OpenAI released GPT-4 to the public for commercial use with full ...
